Ligand Pharmaceuticals
LGND
#3478
Rank
$4.06 B
Marketcap
$206.65
Share price
3.29%
Change (1 day)
94.44%
Change (1 year)

P/S ratio for Ligand Pharmaceuticals (LGND)

P/S ratio as of January 2026 (TTM): 16.0

According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.24. At the end of 2025 the company had a P/S ratio of 13.2.

P/S ratio history for Ligand Pharmaceuticals from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
202513.26.68%
202412.330.17%
20239.4845.3%
20226.53-29.93%
20219.318.57%
20208.58-41.18%
201914.630.16%
201811.2-45.29%
201720.55.1%
201619.5-35.21%
201530.186.35%
201416.1-26.59%
201322.056.36%
201214.180.84%
20117.775.16%
20107.3913.73%
20096.50-31.74%
20089.52-73.03%
200735.3142.56%
200614.6192.86%
20054.97-7.18%
20045.36-29.68%
20037.6291.88%
20023.97-71.82%
200114.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Amgen
AMGN
4.90-69.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
8.22-48.76%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
2.42-84.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
4.33-73.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.30-85.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
16.3 1.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.37-85.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
0.9898-93.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
5.36-66.58%๐Ÿ‡บ๐Ÿ‡ธ USA